GlaxoSmithKline Plc:企業の戦略・SWOT・財務情報

◆英語タイトル:GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4427
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:73
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

GlaxoSmithKline Plc – Strategy, SWOT and Corporate Finance Report
Summary

GlaxoSmithKline Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GlaxoSmithKline plc (GSK or ‘the company’) is a leading global provider of pharmaceuticals, vaccines and consumer healthcare products. It is primarily involved in developing, manufacturing and commercializing pharmaceuticals, vaccines and consumer healthcare products. These cater to the needs of HIV, respiratory, cancer, anti-virals, metabolic, cardiovascular and urogenital, dermatology, anti-bacterials and several other rare diseases. It merchandise and sell these products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in England, the UK.

Scope

- Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis
- An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments
- Intelligence on GlaxoSmithKline Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on GlaxoSmithKline Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
GlaxoSmithKline Plc: Company Overview 9
GlaxoSmithKline Plc: Overview and Key Facts 9
GlaxoSmithKline Plc: Overview 9
GlaxoSmithKline Plc: Key Facts 9
GlaxoSmithKline Plc: Key Employees 11
GlaxoSmithKline Plc: Key Employee Biographies 13
GlaxoSmithKline Plc: Major Products and Services 20
GlaxoSmithKline Plc: Company History 22
GlaxoSmithKline Plc: Management Statement 37
GlaxoSmithKline Plc: Locations and Subsidiaries 39
GlaxoSmithKline Plc: Key Competitors 41
GlaxoSmithKline Plc: Company Analysis 42
GlaxoSmithKline Plc: Business Description 42
GlaxoSmithKline Plc: SWOT Analysis 44
GlaxoSmithKline Plc: SWOT Overview 44
GlaxoSmithKline Plc: Strengths 44
GlaxoSmithKline Plc: Weaknesses 45
GlaxoSmithKline Plc: Opportunities 46
GlaxoSmithKline Plc: Threats 47
GlaxoSmithKline Plc: Corporate Financial Deals Activity 49
GlaxoSmithKline Plc: Financial Deals Overview 49
GlaxoSmithKline Plc: Targets and Partners 51
GlaxoSmithKline Plc: Top Deals 2014 – 2018YTD* 54
GlaxoSmithKline Plc: Advisors 55
GlaxoSmithKline Plc: Top Legal Advisors 55
GlaxoSmithKline Plc: Top Financial Advisors 55
GlaxoSmithKline Plc: Mergers and Acquisitions 57
GlaxoSmithKline Plc: Corporate Venturing 58
GlaxoSmithKline Plc: Capital Raising 59
GlaxoSmithKline Plc: Partnership 60
GlaxoSmithKline Plc: Divestments 61
GlaxoSmithKline Plc: Recent Developments 62
GlaxoSmithKline Plc: News and Events Summary 62
GlaxoSmithKline Plc: Business Expansion 66
GlaxoSmithKline Plc: Business Reorganization 66
GlaxoSmithKline Plc: Contracts 67
GlaxoSmithKline Plc: Financial Deals 67
GlaxoSmithKline Plc: Financial Performance 68
GlaxoSmithKline Plc: Market Developments 68
GlaxoSmithKline Plc: Red Flags/DistressSignals 69
GlaxoSmithKline Plc: Regulatory and Legal Events 69
GlaxoSmithKline Plc: Strategy and Operations 70
Appendix 71
Contact Us 71
Methodology 71
About MarketLine 72

List of Tables
Table 1: GlaxoSmithKline Plc: Key Facts
Table 2: GlaxoSmithKline Plc: Key Employees
Table 3: GlaxoSmithKline Plc: Locations and Subsidiaries
Table 4: GlaxoSmithKline Plc: Key Competitors
Table 5: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Table 7: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Table 9: GlaxoSmithKline Plc: Targets and Partners
Table 10: GlaxoSmithKline Plc: Top Deals 2014 - 2018YTD*
Table 11: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (US$m)
Table 12: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (US$m)
Table 13: GlaxoSmithKline Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: GlaxoSmithKline Plc: M&A Activity by Geography (2014 - YTD*2018)
Table 15: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: GlaxoSmithKline Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: GlaxoSmithKline Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: GlaxoSmithKline Plc: Divestments by Geography (2014 - YTD*2018)
Table 23: GlaxoSmithKline Plc: News and Events Summary
Table 24: GlaxoSmithKline Plc: Business Expansion
Table 25: GlaxoSmithKline Plc: Business Reorganization
Table 26: GlaxoSmithKline Plc: Contracts
Table 27: GlaxoSmithKline Plc: Financial Deals
Table 28: GlaxoSmithKline Plc: Financial Performance
Table 29: GlaxoSmithKline Plc: Market Developments
Table 30: GlaxoSmithKline Plc: Red Flags/DistressSignals
Table 31: GlaxoSmithKline Plc: Regulatory and Legal Events
Table 32: GlaxoSmithKline Plc: Strategy and Operations

List of Figures
Figure 1: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)
Figure 3: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)
Figure 5: GlaxoSmithKline Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: GlaxoSmithKline Plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: GlaxoSmithKline Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: GlaxoSmithKline Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: GlaxoSmithKline Plc: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[GlaxoSmithKline Plc:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CSX Corporation, Inc.:戦略・SWOT・企業財務分析
    CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report Summary CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • NCsoft Corporation (036570):企業の財務・戦略的SWOT分析
    NCsoft Corporation (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Hyperstone GmbH:企業の戦略的SWOT分析
    Hyperstone GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Long Run Exploration Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Long Run Exploration Ltd (Long Run), formerly WestFire Energy Ltd, a subsidiary of Calgary Sinoenergy Investment Corp, is an oil and gas company that offers development and exploration of light oil. The company grows crude oil volumes within its diversified portfolio properties. Its oil expl …
  • JFE Holdings, Inc.:企業の戦略・SWOT・財務情報
    JFE Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JFE Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Travelodge Hotels Ltd.:企業の戦略・SWOT・財務情報
    Travelodge Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary Travelodge Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bioasis Technologies Inc (BTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • ViroGates AS:医療機器:M&Aディール及び事業提携情報
    Summary ViroGates AS (ViroGates) is a meditech company that offers prognostic products. The company develops a prognostic biomarker to make the suPAR test presented as a commercially available test. Its products comprise measures suPAR, quick triage and ELISA. ViroGates’ suparnostic products offer a …
  • Rekah Pharmaceutical Industry Ltd (REKA):企業の財務・戦略的SWOT分析
    Rekah Pharmaceutical Industry Ltd (REKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Bombardier Inc:戦略・SWOT・企業財務分析
    Bombardier Inc - Strategy, SWOT and Corporate Finance Report Summary Bombardier Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Integrated DNA Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services s …
  • Sound Energy plc (SOU):企業の財務・戦略的SWOT分析
    Summary Sound Energy Plc (Sound Energy), formerly Sound Oil plc is an upstream oil and gas company that offers exploration and development of oil and gas properties in Europe and Africa. The company holds interests, owns, and operates the Badile permit located in the Piedmont Lombard Basin in northe …
  • Hydrogenics Corporation (HYG):企業の財務・戦略的SWOT分析
    Hydrogenics Corporation (HYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Campofrio Food Group, S.A.:企業の戦略・SWOT・財務情報
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • High Peak Royalties Limited (HPR):企業の財務・戦略的SWOT分析
    High Peak Royalties Limited (HPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Synopsys Inc (SNPS):企業の財務・戦略的SWOT分析
    Synopsys Inc (SNPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Aleris Corporation:企業のM&A・事業提携・投資動向
    Aleris Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aleris Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • National Institute of Agricultural Research-製薬・医療分野:企業M&A・提携分析
    Summary National Institute of Agricultural Research (INRA) is a research institute that conducts research in agriculture, food, nutrition and food safety, environment and land management. The institute provides healthcare services by conducting research in infectious diseases. It develops various co …
  • Lion Energy Ltd (LIO):企業の財務・戦略的SWOT分析
    Summary Lion Energy Ltd (Lion) is an oil and gas company that explores, develops and produces unconventional oil and gas resources in Indonesia. The company has conventional production sharing contracts such as Seram project and South Block A project. Its Seram project is located on the island of Se …
  • Andorra Banc Agricol Reig SA:企業の戦略・SWOT・財務情報
    Andorra Banc Agricol Reig SA - Strategy, SWOT and Corporate Finance Report Summary Andorra Banc Agricol Reig SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆